Designing an Architecture for Change: Constructing Optimum Treatment Regimens for Type 2 Diabetes CME
Philip Levy, MD, FACE; Lawrence Blonde, MD, FACP, FACE; Paul S. Jellinger, MD, MACE Author Information and Disclosures
Release Date: December 18, 2007; Valid for credit through December 18, 2008
| Physicians - maximum of 1.5 AMA PRA Category 1 Credit(s)™ for physicians |
 |
This program is based on a symposium with the same name that took place April 13, 2007 in Seattle, Washington in conjunction with the American Association of Clinical Endocrinologists (AACE) 16th Annual Meeting and Clinical Congress.
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2007 American Association of Clinical Endocrinologists.
